06:07 AM EDT, 09/14/2026 (MT Newswires) -- UBS Global Research expects the aperitif and ready-to-drink portfolio of Davide Campari-Milano (CPR.MI), d/b/a Campari Group, to bolster the Italian alcoholic beverages company's topline growth trajectory. "Campari is well placed to accelerate organic growth >4% in H2 26, supported by several recently implemented strategic initiatives, including portfolio expansion in Aperitifs and new formats, in particular RTDs. We also see potential upside risk to FY26 gross margin, and a big FY27 free cash flow inflection (UBSe +13% v cons) can support cash return optionality as the company is on the path to becoming more [shareholder-friendly]," analysts said Monday, adding they expect the group to maintain its outperformance against spirits peers. The research firm forecasts the company's full-year 2027 free cash flow to exceed 400 million euros, beating consensus estimates by 14%, as capital expenditure is projected to normalize to 4% to 5% of sales after a five-year "significant" investment cycle. "The c15% share price [pullback] from [year-to-date] highs offers a good entry point, in our view particularly as likely strong Q3 organic sales and potential US tariff refund could be near-term positive catalysts," UBS wrote. Against this backdrop, the research firm upgraded the stock to buy from neutral and raised its price target to 7 euros from 6.10 euros.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.